Madrigal Pharmaceuticals Inc
SWB:YDO1
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
M
|
Madrigal Pharmaceuticals Inc
SWB:YDO1
|
US |
|
N
|
Nissan Chemical Corp
OTC:NNCHY
|
JP |
|
M
|
Mid-America Apartment Communities Inc
F:M2K
|
US |
|
B
|
Biogen Inc
XHAM:IDP
|
US |
|
Tompkins Financial Corp
F:8J0
|
US |
|
C
|
Core Laboratories Inc
F:HJ1
|
US |
|
M
|
Microsoft Corp
XHAM:MSF
|
US |
|
I
|
Industrie De Nora SpA
MIL:DNR
|
IT |
Wall St Price Targets
YDO1 Price Targets Summary
Madrigal Pharmaceuticals Inc
According to Wall Street analysts, the average 1-year price target for YDO1 is 604.56 EUR with a low forecast of 477.99 EUR and a high forecast of 883.81 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is YDO1's stock price target?
Price Target
604.56
EUR
According to Wall Street analysts, the average 1-year price target for YDO1 is 604.56 EUR with a low forecast of 477.99 EUR and a high forecast of 883.81 EUR.
What is the Revenue forecast for Madrigal Pharmaceuticals Inc?
Projected CAGR
27%
Over the last 13 years, the compound annual growth rate for Revenue has been 102%. The projected CAGR for the next 8 years is 27%.
What is the Gross Profit forecast for Madrigal Pharmaceuticals Inc?
Projected CAGR
26%
The compound annual growth rate for Gross Profit over the next 8 years is 26%.
